IRF4 addiction in multiple myeloma

The transcription factor IRF4, required for lymphocyte activation and plasma cell differentiation, is shown here to be a master regulator of multiple myeloma. It controls a different network of genes in the cancer than it does in normal plasma cells or activated B cells.